Bordetella parapertussis isolates not expressing pertactin circulating in France

Clinical Microbiology and Infection

Volumn 17, Issue 5, 2011, Pages 675-682

  Bouchez, V ^a   Brun, D ^a   Dore, G ^a   Njamkepo, E ^a   Guiso, N ^a  

^a CNRS   (France)

Author keywords

B. parapertussis; Bordetella; France; Pathogenicity; Pertactin

Indexed keywords

PERTACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BORDETELLA PARAPERTUSSIS; FRANCE; GENE SEQUENCE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

ANIMALIA; BORDETELLA; BORDETELLA PARAPERTUSSIS;

EID: 79955395031     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03303.x     Document Type: Article

References (30)

1. Watanabe M, Nagai M. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther 2004; 2: 447-454.
2. He QS, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 1998; 280: 635-637.
3. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of Bordetella bronchiseptica. PLoS Pathog 2005; 1: 373-383.
4. Parkhill J, Sebaihia M, Preston A et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 2003; 35: 32-40.
5. Brinig MM, Register KB, Ackermann MR, Relman DA. Genomic features of Bordetella parapertussis clades with distinct host species specificity. Genome Biol 2006; 7: R81.
6. Novotny P. Pathogenesis in Bordetella species. J Infect Dis 1990; 161: 581-583.
7. Caroff M, Aussel L, Zarrouk H et al. Structural variability and originality of the Bordetella endotoxins. J Endotoxin Res 2001; 7: 63-68.
8. Wolfe DN, Buboltz AM, Harvill ET. Inefficient toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS ONE 2009; 4: e4280.
9. Goebel EM, Wolfe DN, Elder K, Stibitz S, Harvill ET. O antigen protects Bordetella parapertussis from complement. Infect Immun 2008; 76: 1774-1780.
10. Zhang X, Rodriguez ME, Harvill ET. O antigen allows Bordetella parapertussis to evade Bordetella pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PLoS ONE 2009; 4: e6989.
11. Fedele G, Nasso M, Spensieri F et al. Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of th17-polarized responses. J Immunol 2008; 181: 208-216.
12. Kourova N, Caro V, Weber C et al. Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains. J Clin Microbiol 2003; 41: 3706-3711.
13. Letowska I, Hryniewicz W. Epidemiology and characterization of Bordetella parapertussis strains isolated between 1995 and 2002 in and around Warsaw, Poland. Eur J Clin Microbiol Infect Dis 2004; 23: 499-501.
14. Makinen J, Mertsola J, Soini H et al. PFGE and pertactin gene sequencing suggest limited genetic variability within the finnish Bordetella parapertussis population. J Med Microbiol 2003; 52: 1059-1063.
15. Khelef N, Danve B, Quentin-Millet MJ, Guiso N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun 1993; 61: 486-490.
16. Donchev D, Stroyanova M. The epidemiological significance of the differentiation of pertussis and parapertussis. J Hyg Epidemiol Microbiol Immunol 1961; 5: 294.
17. Heininger U, Stehr K, Christenson P, Cherry JD. Evidence of efficacy of the lederle/takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. Clin Infect Dis 1999; 28: 602-604.
18. Lautrop H. Epidemics of parapertussis. 20 years' observations in Denmark. Lancet 1971; 1195-1197.
19. Caro V, Njamkepo E, Van Amersfoorth SC et al. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect 2005; 7: 976-982.
20. Bouchez V, Caro V, Levillain E, Guigon G, Guiso N. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS ONE 2008; 3: e2437.
21. Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N. First report and detailed characterization of Bordetella pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 2009; 27: 6034-6041.
22. Boursaux-Eude C, Guiso N. Polymorphism of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchispetica. Infect Immun 2000; 68: 4815-4817.
23. Diavatopoulos DA, Hijnen M, Mooi FR. Adaptive evolution of the Bordetella autotransporter pertactin. J Evol Biol 2006; 19: 1931-1938.
24. Chenal-Francisque V, Caro V, Boursaux-Eude C, Guiso N. Genomic analysis of the adenylate cyclase-hemolysin c-terminal region of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Res Microbiol 2009; 160: 330-336.
25. Betsou F, Sebo P, Guiso N. The c-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun 1995; 63: 3309-3315.
26. Heininger U, Cotter PA, Fescemyer HW et al. Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun 2002; 70: 3777-3784.
27. El-Azami-El-Idrissi M, Bauche C, Loucka J et al. Interaction of Bordetella pertussis adenylate cyclase with cd11b/cd18: role of toxin acylation and identification of the main integrin interaction domain. J Biol Chem 2003; 278: 38514-38521.
28. Bassinet L, Gueirard P, Maitre B, Housset B, Gounon P, Guiso N. Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis. Infect Immun 2000; 68: 1934-1941.
29. Everest P, Li J, Douce G et al. Role of the Bordetella pertussis p.69/pertactin protein and the p.69/pertactin rgd motif in the adherence to and invasion of mammalian cells. Microbiology 1996; 142: 3261-3268.
30. Yih WK, Silva EA, Ida J, Harrington N, Lett SM, George H. Bordetella holmesii-like organisms isolated from Massachussetts patients with pertussis-like symptoms. Emerg Infect Dis 1999; 5: 441-443.